(89)Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe

por Fung, Kimberly, Vivier, Delphine, Keinänen, Outi, Sarbisheh, Elaheh Khozeimeh, Price, Eric W., Zeglis, Brian M.
Publicado 2020

The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and In vivo Performance of (89)Zr-DFO-Pertuzumab

por Vivier, Delphine, Fung, Kimberly, Rodriguez, Cindy, Adumeau, Pierre, Ulaner, Gary A., Lewis, Jason S., Sharma, Sai Kiran, Zeglis, Brian M.
Publicado 2020

Pretargeting of internalizing trastuzumab and cetuximab with a (18)F-tetrazine tracer in xenograft models

por Keinänen, Outi, Fung, Kimberly, Pourat, Jacob, Jallinoja, Vilma, Vivier, Delphine, Pillarsetty, NagaVara Kishore, Airaksinen, Anu J., Lewis, Jason S., Zeglis, Brian M., Sarparanta, Mirkka
Publicado 2017

Harnessing (64)Cu/(67)Cu for a theranostic approach to pretargeted radioimmunotherapy

por Keinänen, Outi, Fung, Kimberly, Brennan, James M., Zia, Nicholas, Harris, Matt, van Dam, Ellen, Biggin, Colin, Hedt, Amos, Stoner, Jon, Donnelly, Paul S., Lewis, Jason S., Zeglis, Brian M.
Publicado 2020